540 Chemie und zugeordnete Wissenschaften
Refine
Has Fulltext
- yes (66)
Is part of the Bibliography
- yes (66)
Year of publication
Document Type
- Doctoral Thesis (46)
- Journal article (20)
Keywords
- Sol-Gel-Verfahren (9)
- Polymere (8)
- Biomaterial (5)
- Beschichtung (4)
- biofabrication (4)
- hydrogels (4)
- Dünne Schicht (3)
- Elektrochemie (3)
- Hydrogel (3)
- Lithium-Ionen-Akkumulator (3)
Institute
- Institut für Funktionsmaterialien und Biofabrikation (66) (remove)
Sonstige beteiligte Institutionen
- Fraunhofer-Institut für Silicatforschung ISC (3)
- Fraunhofer-Institut für Silicatforschung (2)
- Bayerisches Geoinstitut, Universität Bayreuth (1)
- Fraunhofer IOF (1)
- Fraunhofer Institut für Silicatforschung (Würzburg) (1)
- Fraunhofer Institut für Silicatforschung ISC (1)
- Fraunhofer-Institut für Silicatforschung ISC, Würzburg (1)
- Fraunhofer-Institute for Silicate Research ISC (1)
- Hochschule Aalen (1)
- Lehrstuhl für Anorganische Chemie I, Universität Bayreuth (1)
EU-Project number / Contract (GA) number
- 645993 (1)
The present work aims towards the investigation of polymer degradation under biologically relevant conditions. In order to assess a potential degradation of polymers of interest for biomedical applications in vivo and associated effects on living tissue, representatives of poly(2-oxazoline)s and polypeptoids as well as poly(ethylene glycol) and poly(N-vinylpyrrolidone) for reference purposes are examined regarding their stability under oxidative and hydrolytic conditions as well as towards enzymatic degradation.
The polymers investigated in the framework of this thesis are generally considered to be non-biodegradable. Both poly(ethylene glycol) and poly(N-vinylpyrrolidone) are or were applied intensively in vivo provoking seriously harmful side effects like fatal blood poisoning from the oxidation of poly(ethylene glycol) chain ends or poly(N-vinylpyrrolidone) storage disease. Poly(2-alkyl-2-oxazoline)s and polypeptoids, both promising polymeric biomaterials for a wide variety of in vivo applications, are not clinically applied yet but undergo thorough investigations. However, comprising amide bonds within the backbone or the appending side chain, poly(2-alkyl-2-oxazoline)s and polypeptoids potentially offer a higher susceptibility towards (bio-)degradation. Representing the three most impactful initiators of degradation in vivo, the present study is focused on polymer deterioration by oxidative species, hydrolytic conditions and enzymes.
Oxidative species are generated in a variety of processes in vivo, both on purpose and as an unintentional by-product. Previous investigations revealed the susceptibility of poly(ethylene glycol), poly(N-vinylpyrrolidone), poly(2-alkyl-2-oxazoline)s and polypeptoids to deterioration by hydroxyl radicals deriving from hydrogen peroxide and copper ions. The obtained data confirm previous results of an apparent degradation rate increasing with increasing chain length due to self-inhibitory end group effects for all investigated polymer species. Although the exact concentrations of oxidative species in vivo are very controversial, with respect to their great variety and wide distribution the investigated polymers are likely prone to oxidative deterioration to some extent, with rates, mechanisms and degradation products strongly depending on the respective reactive species, polymer structure and chain length.
Like blood, most tissues of the human body benefit from a slightly alkaline pH value. Nevertheless, specific areas like the human stomach or tumor tissues possess acidic conditions potentially capable to cleave amide bonds comprised by poly(2-alkyl-2-oxazoline)s and polypeptoids. Unlike the hydrolysis of poly(2-alkyl-2-oxazoline)s resulting in side chain cleavage, the hydrolysis of polypeptoids induces backbone scission decreasing the polymer chain length tremendously and releasing, if performed exhaustively, the respective amino acids. Hydrolysis of polysarcosine is monitored by quantification of the released sarcosine via 1H-NMR spectroscopy and determination of the residual Mw via GPC. Its cyclic dimer sarcosine anhydride is formed as an intermediate product in this process via cyclization of unstable linear dimers of sarcosine.
Modification and degradation of bio(macro)molecules is an essential part of human metabolism. Polymers bearing amide bonds and showing a great similarity to natural occurring and widely distributed polypeptides, like poly(2-alkyl-2-oxazoline)s and polypeptoids, bear the potential of an enzymatic biodegradability by (more or less specific) peptidases. Just like the acidic hydrolysis described previously, peptidase activity would result in the cleavage of polymer amide bonds. The aim of the present thesis was to evaluate the stability of poly(2-alkyl-2-oxazoline)s and polypeptoids as well as poly(ethylene glycol) for the sake of reference under circumstances resembling in vivo conditions as closely as possible. Initial experiments focused on the degradation of dye-labeled upon incubation with homogenates of freshly harvested rat liver and kidney. However, although the obtained results are promising for the most part, they are considered rather unreliable and non-reproducible for various reasons. More conclusive data are attained from the incubation of non-labeled polymers in freshly laid chicken eggs. While no evidence for an enzymatic digestion of poly(ethylene glycol) in chicken egg white is found and deterioration of poly(2-methyl-2-oxazoline) upon incubation apparently derives from non-enzymatic hydrolysis, incubated polysarcosine samples reveal distinct elugram patterns depending on the respective C- and N-terminal end groups indicating both exopeptidase and endopeptidase activity. It has to be kept in mind though, that an enzymatic digestibility of polysarcosine does not necessarily imply the digestion of polypeptoids bearing longer side chains by peptidases as well, which should be investigated in further studies.